Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
975,530
-
Shares change
-
+20,779
-
Total reported value, excl. options
-
$42,694,000
-
Value change
-
+$910,265
-
Number of buys
-
9
-
Number of sells
-
-3
-
Price
-
$43.76
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q2 2017
12 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q2 2017.
NOVOZYMES A S DKK 2.0 - COM has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 975,530 shares
.
Largest 10 shareholders include SOMERVILLE KURT F (254,805 shares), Hemenway Trust Co LLC (195,280 shares), Kidder Stephen W (125,931 shares), Broderick Brian C (120,665 shares), PUZO MICHAEL J (86,485 shares), Page Arthur B (45,740 shares), Fayerweather Charles (30,883 shares), Gardiner Nancy B (29,420 shares), Delaney Dennis R (28,938 shares), and Notis-McConarty Edward (27,296 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.